Paramyxovirus fusion protein: Characterization of the core trimer, a rod-shaped complex with helices in anti-parallel orientation

Virology

Volumn 254, Issue 1, 1999, Pages 147-159

  Dutch, Rebecca Ellis ^a   Leser, George P ^a   Lamb, Robert A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYPEPTIDASE; HEMAGGLUTININ; HYBRID PROTEIN;

ARTICLE; DIGESTION; ELECTRON MICROSCOPY; ENZYME ACTIVITY; GENE MUTATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MUTAGENESIS; NUCLEAR MAGNETIC RESONANCE; PARAMYXOVIRUS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION; THERMOSTABILITY;

EID: 0033080395     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9532     Document Type: Article

References (52)

1. Asano, K., and Asano, A. (1985). Why is a specific amino acid sequence of F glycoprotein required for the membrane fusion reaction between envelope of HVJ (Sendai virus) and target cell membranes? Biochem. Int. 10, 115-122.
2. Bagai, S., and Lamb, R. A. (1995). Quantitative measurement of paramyxovirus fusion: Differences in requirements of glycoproteins between simian virus 5 and human parainfluenza virus 3 or Newcastle disease virus. J. Virol. 69, 6712-6719.
3. Blacklow, S. C., Lu, M., and Kim, P. S. (1995). A trimeric subdomain of the simian immunodeficiency virus envelope glycoprotein. Biochemistry 34, 14956-14962.
4. Buckland, R., Malvoisin, E., Beauverger, P., and Wild, F. (1992). A leucine freedmenzipper structure present in the measles virus fusion protein is not required for its tetramerization but is essential for fusion. J. Gen. Virol. 73, 1703-1707.
5. Bullough, P. A., Hughson, F. M., Skehel, J. J., and Wiley D. C. (1994). Structure of influenza haemagglutinin at the pH of membrane fusion. Nature 371, 37-43.
6. Caffrey, M., Cai, M., Kaufman, J., Stahl, S. J., Gronenborn, A. M., and Clore, G. M. (1998). Three-dimensional solution structure of the 44 kda ectodomain of SIV gp41. EMBO J. 17, 4572-4584.
7. Cao, J., Bergeron, L., Helseth, E., Thali, M., Repke, H., and Sodroski, J. (1993). Effects of amino acid changes in the extracellular domain of the human immunodeficiency virus type 1 gp41 envelope glycoprotein. J. Virol. 67, 2747-2755.
8. Carr, C. M., and Kim, P. S. (1993). A spring-loaded mechanism for the conformational change of influenza hemagglutinin. Cell 73, 823-832.
9. Chambers, P., Pringle, C. R., and Easton, A. J. (1990). Heptad repeat sequences are located adjacent to hydrophobic regions in several types of virus fusion glycoproteins. J. Gen. Virol. 71, 3075-3080.
10. Chan, D. C., Fass, D., Berger, J. M., and Kim, P. S. (1997). Core structure of gp41 from the HIV envelope glycoprotein. Cell 89, 263-273.
11. Chen, J., Wharton, S. A., Weissenhorn, W., Calder, L. J., Hughson, F. M., Skehel, J. J., and Wiley, D. C. (1995). A soluble domain of the membrane-anchoring chain of influenza virus hemagglutinin (HA2) folds in Escherichia coli into a low-pH-induced conformation. Proc. Natl. Acad. Sci. USA 92, 12205-12209.
12. Chen, S. S.-L., Lee, C.-N., Lee, W.-R., McIntosh, K., and Lee, T.-H. (1993). Mutational analysis of the leucine zipper-like motif of the human immunodeficiency virus type 1 envelope transmembrane glycoprotein. J. Virol. 67, 3615-3619.
13. Damico, R. L., Crane, J., and Bates, P. (1998). Receptor-triggered membrane association of a model retroviral glycoprotein. Proc. Natl. Acad. Sci. USA 95, 2580-2585.
14. Deng, W. P., and Nickoloff, J. A. (1992). Site-directed mutagenesis of virtually any plasmid by eliminating a unique site. Anal. Biochem. 200, 81-88.
15. Fass, D., Harrison, S. C., and Kim, P. S. (1996). Retrovirus envelope domain at 1.7Å resolution. Nat. Struct. Biol. 3, 465-469.
16. Ghosh, J. K., Ovadia, M., and Shai, Y. (1997). A leucine zipper motif in the ectodomain of Sendai virus fusion protein assembles in solution and in membranes and specifically binds biologically-active peptides and the virus. Biochemistry 36, 15451-15462.
17. Ghosh, J. K., Peisajovich, S. G., Ovadia, M., and Shai, Y. (1998). Structure-function study of a heptad repeat positioned near the transmembrane domain of Sendai virus fusion protein which blocks virus-cell fusion. J. Biol. Chem. 273, 27182-27190.
18. Gill, S. C., and von Hippel, P. H. (1989). Calculation of protein extinction coefficients from amino acid sequence data. Anal. Biochem. 182, 319-326.
19. Hart, T. S., Kirsh, R., Ellens, H., Sweet, R. W., Lambert, D. M., Petteway, S. R., Leary, J., and Bugelski, P. J. (1991). Binding of soluble CD4 proteins to human immunodeficiency virus type 1 and infected cells induces release of envelope glycoprotein gp120. Proc. Natl. Acad. Sci. USA 88, 2189-2193.
20. Hernandez, L. D., Peters, R. J., Delos, S. E., Young, J. A. T., Agard, D. A., and White, J. M. (1997). Activation of a retroviral membrane fusion protein: Soluble receptor-induced liposome binding of the ALSV envelope glycoprotein. J. Cell Biol. 139, 1455-1464.
21. Hughson, F. M. (1997). Enveloped viruses: A common mode of membrane fusion? Curr. Biol. 7, R565-R569.
22. Jiang, S., Lin, K., Strick, N., and Neurath, A. R. (1993a). HIV-1 inhibition by a peptide [letter]. Nature 365, 113.
23. Jiang, S., Lin, K., Strick, N., and Neurath, A. R. (1993b). Inhibition of HIV-1 infection by a fusion domain binding peptide from the HIV-1 envelope glycoprotein GP41. Biochem. Biophys. Res. Commun. 195, 533-538.
24. Joshi, S. B., Dutch, R. E., and Lamb, R. A. (1998). A core trimer of the paramyxovirus fusion protein: Parallels to influenza virus hemagglutinin and HIV-1 gp41. Virology. 248, 20-34.
25. Klenk, H.-D., and Garten, W. (1994). Host cell proteases controlling virus pathogenicity. Trends Microbiol. 2, 39-43.
26. Lamb, R. A. (1993). Paramyxovirus fusion: A hypothesis for changes. Virology 197, 1-11.
27. Lambert, D. M., Barney, S., Lambert, A. L., Guthrie, K., Medinas, R., Davis, D. E., Bucy, T., Erickson, J., Merutka, G., and Pettaway, S. R., Jr. (1996). Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion. Proc. Natl. Acad. Sci. USA 93, 2186-2191.
28. Lu, M., Blacklow, S. C., and Kim, P. S. (1995). A trimeric structural domain of the HIV-1 transmembrane glycoprotein. Nature Struct. Biol. 2, 1075-1082.
29. Malashkevich, V. N., Chan, D. C., Chutkowski, C. T., and Kim, P. S. (1998). Crystal structure of the simian immunodeficiency virus (SIV) gp41 core: Conserved helical interactions underlie the broad inhibitory activity of gp41 peptides. Proc. Natl. Acad. Sci. USA 95, 9134-9139.
30. Moore, J. P., McKeating, J. A., Weiss, R. A., and Sattentau, Q. J. (1990). Dissociation of gp120 from HIV-1 virions induced by soluble CD4. Science 250, 1130-1142.
31. Munoz-Barroso, I., Durell, S., Sakaguchi, K., Appella, E., and Blumenthal, R. (1998). Dilation of the human immunodeficiency virus-1 envelope glycoprotein fusion pore revealed by the inhibitory action of a synthetic peptide from gp41. J. Cell Biol. 140, 315-323.
32. Novick, S. L., and Hoekstra, D. (1988). Membrane penetration of Sendai virus glycoproteins during the early stage of fusion with liposomes as determined by hydrophobic affinity labeling. Proc. Natl. Acad. Sci. USA 85, 7433-7437.
33. Paterson, R. G., and Lamb, R. A. (1993). The molecular biology of influenza viruses and paramyxoviruses. Molecular Virology: A Practical Approach (A. Davidson and R. M. Elliott, Eds.), pp. 35-73. IRL Oxford University Press, Oxford.
34. Rapaport, D., Ovadia, M., and Shai, Y. (1995). A synthetic peptide corresponding to a conserved heptad repeat domain is a potent inhibitor of Sendai virus-cell fusion: An emerging similarity with functional domains of other viruses. EMBO J. 14, 5524-5531.
35. Rimsky, L. T., Shugars, D. C., and Matthews, T. J. (1998). Determinants of human immunodeficiency virus type 1 resistance to gp41-derived inhibitory peptides. J. Virol. 72, 986-993.
36. Ruigrok, R. W., Aitken, A., Calder, L. J., Martin, S. R., Skehel, J. J., Wharton, S. A., Weis, W., and Wiley, D. C. (1988). Studies on the structure of the influenza virus haemagglutinin at the pH of membrane fusion. J. Gen. Virol. 69, 2785-2795.
37. Russell, R., Paterson, R. G., and Lamb, R. A. (1994). Studies with cross-linking reagents on the oligomeric form of the paramyxovirus fusion protein. Virology 199, 160-168.
38. Schagger, H., and Von Jagow, G. (1987). Tricine-sodium dodecylsulfate-polyacrylamide gel electrophoresis for the separation of protein in the range from 1 to 100 kDa. Anal. Biochem. 166.
39. Scheid, A., and Choppin, P. W. (1974). Identification of biological activities of paramyxovirus glycoproteins. Activation of cell fusion, hemolysis, and infectivity of proteolytic cleavage of an inactive precursor protein of Sendai virus. Virology 57, 475-490.
40. Sergel-German, T., McQuain, C., and Morrison, T. (1994). Mutations in the fusion peptide and heptad repeat regions of the Newcastle disease virus fusion protein block fusion. J. Virol. 68, 7654-7658.
41. Stennicke, H. R., Mortensen, U. H., Christensen, U., Remington, S. J., and Breddam, K. (1994). Effects of introduced aspartic and glutamic acid residues on the P′1 substrate specificity, pH dependence and stability of carboxypeptidase Y. Prot. Eng. 7, 911-916.
42. Tan, K., Liu, J.-H., Wang, J.-H., Shen, S., and Lu, M. (1997). Atomic structure of a thermostable subdomain of HIV-1 gp41. Proc. Natl. Acad. Sci. USA 94, 12303-12308.
43. Weissenhorn, W., Calder, L. J., Wharton, S. A., Skehel, J. J., and Wiley, D. C. (1998). The central structural feature of the membrane fusion protein subunit from the Ebola virus glycoprotein is a long triple-stranded coiled coil. Proc. Natl. Acad. Sci. USA 95, 6032-6036.
44. Weissenhorn, W., Dessen, A., Harrison, S. C., Skehel, J. J., and Wiley, D. C. (1997). Atomic structure of the ectodomain from HIV-1 gp41. Nature 387, 426-430.
45. Weissenhorn, W., Wharton, S. A., Calder, L. J., Earl, P. L., Moss, B., Aliprandis, E., Skehel, J. J., and Wiley, D. C. (1996). The ectodomain of HIV-1 env subunit gp41 forms a soluble, α-helical, rod-like oligomer in the absence of gp120 and the N-terminal fusion peptide. EMBO J. 15, 1507-1514.
46. Wild, C., Oas, T., McDanal, C., Bolognesi, D., and Matthews, T. (1992). A synthetic peptide inhibitor of human immunodeficiency virus replication: Correlation between solution structure and viral inhibition. Proc. Natl. Acad. Sci. USA 89, 10537-10541.
47. Wild, C. T., Shugars, D. C., Greenwell, T. K., McDanal, C. B., and Matthews, T. J. (1994). Peptides corresponding to a predictive α-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection. Proc. Natl. Acad. Sci. USA 91, 9770-9774.
48. Wilson, I. A., Skehel, J. J., and Wiley, D. C. (1981). Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution. Nature 289, 366-375.
49. Wrigley, N. G., Brown, E., and Chillingworth, R. K. (1982). Combining accurate defocus with low-dose imaging in high resolution electron microscopy of biological material. J. Microsc. 130, 225-232.
50. Yao, Q., and Compans, R. W. (1996). Peptides corresponding to the heptad repeat sequence of human parainfluenza virus fusion protein are potent inhibitors of virus infection. Virology 223, 103-112.
51. Young, J. K., Hicks, R. P., Wright, G. E., and Morrison, T. G. (1997). Analysis of a peptide inhibitor of paramyxovirus (NDV) fusion using biological assays, NMR, and molecular modeling. Virology 238, 291-304.
52. Zhou, J., Dutch, R. E., and Lamb, R. A. (1997). Proper spacing between heptad repeat B and the transmembrane domain boundary of the paramyxovirus SV5 F protein is critical for biological activity. Virology 239, 327-339.